Milad Alucozai

Hometown: West Lafayette, IN
Colleges: College of Health and Human Sciences, University Honors Program
Major: Brain and Behavioral Sciences, Class of 2014

Purdue Alumnus Milad Alucozai is a finalist for the Marshall Scholarship. Marshall Scholars are positioned to be world leaders who build on the strength of the enduring relationship between the British and American peoples, their governments, and their institutions to improve the lives of others. Alucozai holds a B.S. in Brain and Behavioral Sciences, a Certificate in Entrepreneurship and Innovation, and a minor in Political Science. “The best way to tackle mental health is through an interdisciplinary approach,” he states, and he seeks novel approaches to treatment from both medical and social perspectives.

Alucozai is currently completing his Master’s in Immunology and Global Health at Maynooth University in Ireland through the Mitchell Scholarship. His thesis research is based in the neurological drug development and imaging group. He has continually sought global discourse on health, formerly traveling to Nepal, Colombia, and Ethiopia for research-based, humanitarian projects. He recently served as a mentor for the Clinton Global Initiative University, supporting “commitment-makers” around the world. As a serial entrepreneur, he invented four lab-based technologies and has been active in numerous start-ups across various fields. He is Co-Founder and COO of Symmetry Therapeutics, Inc., a biotech company translating patented scientific advances into novel therapeutics. Alucozai is currently advising Living On One, a film production studio that recently premiered Salam Neighbor, a documentary on the refugee crisis. He plans to use film to advocate for mental health issues.


Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

2014 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by NISO Office

If you have trouble accessing this page because of a disability, please contact NISO at